Fundraising FoxCurative Ventures
Venture capitalDallas · 1 people tracked
Also known as CURATIVE VENTURES MANAGEMENT LLC
Find your way into Curative Ventures
Sign up to see every warm intro you have to Curative Ventures
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Curative Ventures team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Curative Ventures backs category-defining biotech companies working on novel therapies designed to dramatically improve patient outcomes. Acting as both a capital and talent partner, the firm supports companies advancing new treatments across areas such as oncology and other therapeutic domains. Its investment activity, evidenced by companies like Instil Bio, Peloton Therapeutics, Exonics, and TCR2 Therapeutics, spans developments through IPOs and acquisitions.
Source: firm website, verified Sep 29, 2026.
Team · 1 people
from public directoriesWhat they invest in
from 2 of 6 portfolio companiesBiotech ×2Digital Health ×1Medical Devices ×1
HQs:United States×2
Investments · 6 tracked
founders shown can be your intro path
Instil Bio is a biotechnology company that identifies and acquires or licenses therapeutic candidates for development, with a strategic focus on securing additional novel drug candidates targeting diseases with significant unmet medical needs.
BiotechDallas, US
Bronson Crouch(Chief Executive Officer / Chairman of the Board)inSandeep "Steve" Laumas(Chief Financial Officer & Chief Business Officer)inNimish Shah(Director)inGwen Binder(Director)Neil Gibson(Director)George Matcham(Director)
Co-investorsVivo CapitalWellington ManagementCPMGVenrock
ImmuneOnco Biopharmaceuticals is a Shanghai-founded clinical-stage biotech developing bispecific antibodies and Fc-fusion proteins for immuno-oncology and other diseases.
Peloton Therapeutics is a clinical-stage pharmaceutical company developing first-in-class small molecule medicines targeting HIF-2α for cancer and other life-threatening conditions, with initial focus on kidney cancer and VHL disease.
BiotechDigital HealthMedical Devices
Co-investorsForesite CapitalNextech InvestRidgeback CapitalThe Column GroupVida Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
ExonicsiTeos TherapeuticsTCR2 Therapeutics
Exits · 4
1 IPOs · 3 acquisitionsInstil BioNASDAQ: TILExonicsacq. by VertexPeloton Therapeuticsacq. by MerckTCR2 Therapeuticsacq. by Adaptimmune Therapeutics plc
IPO stake values · per SEC filings
Value of this firm's stake in each portfolio company at its IPO price, from the prospectus principal-stockholder table.
| Company | Owned | IPO price | At IPO | Stake value |
|---|---|---|---|---|
| Instil Bio | 29.7% | $20.00 | Mar 2021 | $750.6M |
Source: SEC S-1 / 424B prospectus filings. Stake value = shares beneficially owned × the initial public offering price, as disclosed — a market value at IPO, not a return multiple (the firm's original cost is not disclosed).
Frequently asked questions
- How many investments has Curative Ventures made?
- Curative Ventures has 6 tracked investments, 4 of which have exited.
- What sectors does Curative Ventures focus on?
- Curative Ventures focuses on Biotech.
- Where is Curative Ventures located?
- Curative Ventures is headquartered in Dallas, US.
- Who does Curative Ventures co-invest with?
- Curative Ventures most often shares deals with Foresite Capital, The Column Group, Vida Ventures, among 7 tracked co-investors.
Similar investors
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
Andreessen Horowitz (a16z) is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz, known for pioneering the platform model with a large team of operators supporting founders across stages.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.